Valuation: Makers Laboratories Limited

Market Cap 1.09B 11.41M 10.05M 9.52M 8.6M 16.2M 16.41M 114M 43.84M 559M 42.85M 41.92M 1.79B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 1.04B 10.82M 9.53M 9.03M 8.15M 15.36M 15.56M 108M 41.58M 531M 40.64M 39.75M 1.7B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
31.45%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Makers Laboratories Limited

1 day-2.02%
1 week-1.52%
Current month-2.02%
1 month-2.42%
3 months+24.58%
6 months+34.39%
Current year+53.79%
1 week 174.75
Extreme 174.75
195.65
1 month 171
Extreme 171
217.5
Current year 112.1
Extreme 112.1
236.55
1 year 109
Extreme 109
236.55
3 years 103.85
Extreme 103.85
236.55
5 years 94
Extreme 94
236.55
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Director of Finance/CFO 59 2017-10-29
Compliance Officer - 2024-05-22
Sales & Marketing 54 2017-08-01
Director TitleAgeSince
Director/Board Member 79 2009-04-28
Chairman 77 2019-03-27
Director/Board Member 51 2011-08-10
Change 5-day change 1-year change 3-year change Capi.($)
-2.02%-1.52%+39.77%+68.40% 11.41M
-1.04%-3.19%+38.61%+112.55% 1,031B
-0.94%-2.97%+41.16%+69.27% 638B
-0.85%-1.91%+6.41%+75.41% 462B
-0.65%-2.40%+60.25%+40.84% 359B
-0.29%-4.18%+23.34%+40.37% 335B
-1.81%-0.86%+13.38%+26.31% 273B
-1.95%-2.63%-2.91%+10.26% 253B
-1.51%+2.39%+39.28%+56.12% 228B
-0.96%-1.17%+33.10%+99.65% 185B
Average -1.21%-0.28%+29.24%+59.92% 376.39B
Weighted average by Cap. -1.03%-0.35%+30.94%+70.22%

Financials

2025 2026
Net sales 1.21B 12.59M 11.09M 10.51M 9.49M 17.88M 18.11M 126M 48.38M 617M 47.29M 46.26M 1.98B 1.41B 14.69M 12.94M 12.26M 11.07M 20.86M 21.13M 147M 56.44M 720M 55.17M 53.97M 2.31B
Net income 74.91M 781K 688K 652K 588K 1.11M 1.12M 7.8M 3M 38.29M 2.93M 2.87M 123M 23.51M 245K 216K 205K 185K 348K 353K 2.45M 942K 12.02M 921K 901K 38.54M
Net Debt 48.19M 503K 443K 419K 379K 714K 723K 5.02M 1.93M 24.64M 1.89M 1.85M 78.99M -56.5M -589K -519K -492K -444K -837K -847K -5.88M -2.26M -28.88M -2.21M -2.16M -92.6M
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
26-10-01 ₹181.70 -2.02% 1,157
26-09-30 ₹185.45 -1.33% 285
26-09-29 ₹187.95 -0.16% 719
26-09-28 ₹188.25 0.00% 1,007
26-09-25 ₹188.25 +0.67% 170
  1. Stock Market
  2. Stocks
  3. MAKERSL Stock